Your browser doesn't support javascript.
loading
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
Xu, Bin; Dong, San-Yuan; Bai, Xue-Li; Song, Tian-Qiang; Zhang, Bo-Heng; Zhou, Le-Du; Chen, Yong-Jun; Zeng, Zhi-Ming; Wang, Kui; Zhao, Hai-Tao; Lu, Na; Zhang, Wei; Li, Xu-Bin; Zheng, Su-Su; Long, Guo; Yang, Yu-Chen; Huang, Hua-Sheng; Huang, Lan-Qing; Wang, Yun-Chao; Liang, Fei; Zhu, Xiao-Dong; Huang, Cheng; Shen, Ying-Hao; Zhou, Jian; Zeng, Meng-Su; Fan, Jia; Rao, Sheng-Xiang; Sun, Hui-Chuan.
Affiliation
  • Xu B; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Dong SY; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, Shanghai, China.
  • Bai XL; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Song TQ; Department of Hepatobiliary, National Clinical Research Center of Cancer, Oncology Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Zhang BH; Department of Hepatic Oncology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
  • Zhou LD; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • Chen YJ; Department of Hepatobiliary Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zeng ZM; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Wang K; Department of Hepatic Surgery II, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, China.
  • Zhao HT; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Lu N; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang W; Department of Hepatobiliary, National Clinical Research Center of Cancer, Oncology Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Li XB; Department of Radiology, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Zheng SS; Department of Hepatic Oncology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
  • Long G; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • Yang YC; Department of Hepatobiliary Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Huang HS; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Huang LQ; Department of Hepatic Surgery II, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai, China.
  • Wang YC; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liang F; Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhu XD; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Huang C; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shen YH; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhou J; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zeng MS; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, Shanghai, China.
  • Fan J; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Rao SX; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Medical Imaging, Shanghai, China.
  • Sun HC; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
Liver Cancer ; 12(3): 262-276, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37601982
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Liver Cancer Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Liver Cancer Year: 2023 Document type: Article Affiliation country: